Patient reads a prescription
·
3 Min Read

New FDA opioid labeling keep focus on individualized care

Agency action updates medication risk information and supports prescribing decisions tailored to individual patient needs. 

Behavioral Health
Physician working on an opioid prescription on the computer.
·
4 Min Read

Teaching resident physicians about safe opioid prescribing

Opioids can be an effective treatment for chronic pain, but prescribing them properly requires prudence. Learn more with the AMA.

series
Improve GME
Thriving in Residency
·
2 Min Read

AMA advocacy delivers modernized e-prescribing standard

The Department of Health and Human Services has adopted electronic prescribing standards that reflect key recommendations from the AMA.

Press Releases
Person's hand embraces another's shoulders during a group discussion
·
5 Min Read

New tool brings mental health parity problems to light

The AMA collaborates on a tool to identify inequities in access, coverage and payment for mental health and substance-use services. 

Behavioral Health
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Aug. 11, 2025

In the news: Using tech may reduce risk of dementia, “clear vapes” may be more harmful than flavored e-cigarettes, adoption of AI outpaces governance and more.

Publications & Newsletters
Crouching figure holding up a giant pill
·
4 Min Read

In PBM market, competition is hard to come by

AMA analysis details low competition in a market that is drawing scrutiny from Congress and regulators.

Access to Care
Balanced pills and supplements
·
4 Min Read

A handful of PBMs have nearly 70% share in 3 product markets

New evidence sheds light on the need for more transparency and oversight of pharmacy benefit manager (PBM) policies and practices. Learn more.

Access to Care
Elderly person holds a box of medication
·
4 Min Read

Unchecked power in PBM industry puts patients at risk of harm

The combination of low competition among pharmacy benefit managers and high vertical integration with insurers poses significant risk for patients.

series
Leadership
Leadership Viewpoints
·
1 Min Read

On opioid labeling, FDA emphasizes patient-physician relationship

The AMA commends the FDA for new label requirements for opioids that emphasizes shared decision-making between the patient and physician.

Press Releases